Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biologics. 2010 Jun 24;4:157-62.

Decreasing glioma recurrence through adjuvant cancer stem cell inhibition.

Author information

  • 1Division of Neurosurgery, City of Hope National Cancer Center, Duarte, CA, USA.

Abstract

Gliomas remain one of the most challenging solid organ tumors to treat and are marked clinically by invariable recurrence despite multimodal intervention (surgery, chemotherapy, radiation). This recurrence perhaps, is as a consequence of the failure to eradicate a tumor cell subpopulation, termed cancer stem cells. Isolating, characterizing, and understanding these tumor-initiating cells through cellular and molecular markers, along with genetic and epigenetic understanding will allow for selective targeting through therapeutic agents and holds promise for decreasing glioma recurrence.

KEYWORDS:

cancer stem cells; epigenetic; glioma

PMID:
20631819
[PubMed]
PMCID:
PMC2898103
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk